Veldoreotide


CAS No. : 252845-37-7

(Synonyms: DG3173; PTR-3173)

252845-37-7
Price and Availability of CAS No. : 252845-37-7
Size Price Stock
100 mg Get quote
250 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-P0024
M.Wt: 1123.30
Formula: C60H74N12O10
Purity: >98 %
Solubility: 10 mM in DMSO
Introduction of 252845-37-7 :

Veldoreotide (DG3173) a somatostatin analogue, binds to and activate the somatostatin receptors (SSTR) 2, 4, and 5. Veldoreotide inhibits growth hormone (GH) secretion in adenomas compared with Octreotide (HY-P0036). Veldoreotide has the potential to be used as pain modulating agent[1] IC50 & Target:EC50: 37.6 ± 4.5 nM (GIRK2-SST2); 31.3 ± 14.4 nM (GIRK2-SST4), 10.5 ± 3.4 nM (GIRK2-SST5)[1] IC50: 0.49 nM (GH)[2] In Vitro:Veldoreotide stimulates the SST2, SST4, and SST5 receptors with high potency and efficacy in the HEK293 cells, co-expressing these receptors with the GIRK2 channels; EC50s of 37.6 ± 4.5 nM, 31.3 ± 14.4 nM and 10.5 ± 3.4 nM for GIRK2-SST2, GIRK2-SST4 and GIRK2-SST5, respectively[1].
Veldoreotide (10 μM; 24 h) inhibits SST4-expressing BON-1 cells[1].
Veldoreotide (DG3173) (100 nM or 1 μM; 6 h) inhibits GH secreation in adenomas with an IC50 of 0.49 nM[2].

Your information is safe with us.